Extension action in the face of the SARS-CoV-2 pandemic
The role of the UFV-CRP Molecular Diagnostics Laboratory and university protagonism
DOI:
https://doi.org/10.30712/guara.v1i15.38281Keywords:
Pandemic, COVID-19, RT-qPCR, University extensionAbstract
With the health crisis established in early 2020, members of the academic community of the Federal University of Viçosa - Cam-pus Rio Paranaíba (UFV-CRP) proposed the creation of a SARS--CoV-2 diagnostic laboratory, by RT-qPCR. The purpose of this article is to report how the joint effort between the university, public and private institutions successfully promoted the installation of a testing laboratory on a new campus, outside the university headquarters, in the face of COVID-19. In almost two years of activity, the Molecular Diagnostics Laboratory (MDL) served 22 cities in the Alto Paranaíba/MG region and released 25,201 tests. In addition, MDL also trained undergraduate and graduate students in molecular diagnostic techniques for the coronavirus, acted in the fight against the spread of false in-formation on social networks and the spread of COVID-19 prophylactic methods. The installation of MDL provided the creation of a theoretical and practical discipline about the disease, and strengthened research on campus, allowing scientific ini-tiation projects related to COVID-19 to be carried out, with re-sults published in internationally indexed scientific journals.
Downloads
References
BRASIL. (2022). Ministério da Saúde. Boletim Epidemiológico Especial: Doença pelo Novo Coronavírus- CO-VID-19, n. 112. Publicado em: 13 de maio de 2022. Disponível em: https://www.gov.br/saude/pt-br/centrais--de-conteudo/publicacoes/boletins/boletins-epidemiologicos/covid-19/2022/boletim-epidemiologico-no--112-boletim-coe-coronavirus.pdf/view. Acesso em: 16 maio 2022.
BRITO, S.B.P.; BRAGA, I.O.; CUNHA, C.C.; PALÁCIO, M. A.V.; TAKENAMI I. Pandemia da COVID-19: o maior desafio do século XXI. Revista Visa em Debate: Sociedade, Ciência e Tecnologia, 8(2), 54-63, 2020.
CERAOLO, C.; GIORGI, F. M. Genomic variance of the 2019-nCoV coronavirus. Journal of Medical Virology, 92, 522-529, publicado em 02 fevereiro 2020.
FÓRUM DE PRÓ-REITORES DE EXTENSÃO DAS INSTITUIÇÕES PÚBLICAS DE EDUCAÇÃO SUPERIOR BRASILEIRAS (FORPROEX). Política Nacional de Extensão Universitária. Manaus, AM, 2012, 40p.
FUNDAÇÃO EZEQUIEL DIAS (FUNED). Dezenove laboratórios são habilitados pela Funed para o teste de coronavírus em MG. Publicado em: 02/04/2020. Disponível em: http://www.funed.mg.gov.br/2020/04/destaque/dezenove-laboratorios-sao-habilitados-para-o-teste-de-coronavirus-em-mg/. Acesso em: 30 abr. 2022.
GARCIA, L.P.; DUARTE, E. Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil. Epidemiologia e Serviços de Saúde, 29(2), e2020222, 2020.
GATTAI, S.; BERNARDES, M. A. Papel e responsabilidades da universidade no processo socioeducativo pre-sente em movimentos de economia solidária. Revista de Administração Mackenzie, 14(6), 50-81, 2013.
GIMENEZ, A.M.N.; SOUZA, G.; FELTRIN, R.B. Para além do ensino, da pesquisa e da extensão: iniciativas e res-postas das universidades brasileiras para o enfrentamento da COVID-19. Revista Tecnologia e Sociedade, 16(43), 116-137, ed. especial, 2020.
INSTITUTO BUTANTAN. Por que acontecem mutações do SARS-CoV-2 e quais as diferenças entre cada uma das variantes. Publicado em: 09/09/2021. Disponível em: https://butantan.gov.br/noticias/por-que-acontecem--mutacoes-do-sars-cov-2-e-quais-as-diferencas-entre-cada-uma-das-variantes. Data de acesso: 29 abr. 2022.
LISBOA, A. P. Universidades e Institutos federais fizeram 1.665 ações contra COVID-19. Correio Braziliense, publicado em 07 de julho de 2020. Disponível em: https://www.correiobraziliense.com.br/app/noticia/eu-estu-dante/ensino_educacaobasica/2020/07/07/interna-educacaobasica-universidades-e-institutos-federais-fizeram-1-665-acoes-contra-covid.shtml. Acesso em: 29 abr. 2022.
MADRUGA, S.W. Editorial. Revista Expressa Extensão, 25(2), publicado em abril de 2020.ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE – OPAS. Histórico da pandemia de COVID-19 (on-line). Disponível em: https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19. Acesso em: 29 abr. 2022.
UZUNIAN, A. Coronavirus SARS-CoV-2 and COVID-19. Jornal Brasileiro de Patologia Laboratorial, 56, 1-4, publicado em 09 setembro 2020.
WORLD HEALTH ORGANIZATION - WHO. Coronavirus disease (COVID-19) pandemic (on-line). Disponível em: https://www.who.int/emergencies/diseases/novelcoronavirus-2019. Acesso em: 29 abr. 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Guará Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Revista Guará adopts the Creative Commons Attribution 4.0 International (CC BY 4.0) license, under which authors retain copyright over their submitted and published works.
Authors are responsible for declaring that the submitted manuscript is original, has not been previously published, and is not under simultaneous consideration by another journal. Upon submission, manuscripts undergo a peer review process.
By submitting a manuscript, authors grant Revista Guará the right of first publication, while remaining free to enter into additional non-exclusive distribution agreements for the published version (for example, in institutional repositories, personal websites, or as part of future works), provided that proper credit is given to the authors and to the original publication in the journal.
Revista Guará encourages the broad dissemination of published works, including their availability in institutional repositories and other platforms, as a way to increase the visibility and impact of scientific production.
Under the CC BY 4.0 license, users are allowed to:
- Share — copy and redistribute the material in any medium or format;
- Adapt — remix, transform, and build upon the material for any purpose, including commercial use.
These rights are irrevocable, provided that the following terms are respected:
- Attribution — appropriate credit must be given to the authors, a link to the license must be provided, and any changes made must be indicated. Attribution must be made in a reasonable manner, without suggesting endorsement by the authors or the journal.
The license does not impose additional restrictions. Users may not apply legal terms or technological measures that legally restrict others from exercising the rights granted by the license.
